Eli Lilly Takes Legal Action Against Clinics Selling Counterfeit Mounjaro Diabetes Drug

Eli Lilly has filed lawsuits against 10 medical spas, wellness clinics, and compounding pharmacies across the U.S. for allegedly selling unauthorized versions of its diabetes drug, Mounjaro. The company accuses these establishments of marketing and selling "compounded" drug products claiming to contain tirzepatide, the active ingredient in Mounjaro. Eli Lilly, the sole patent holder of tirzepatide, is seeking court orders to block the sales of counterfeit versions and monetary damages. This action comes as Eli Lilly faces a shortage of Mounjaro due to high demand, with the drug's off-label use for weight loss contributing to its popularity.